Switch to the original HML Online view

Hospital Medicines List

Enter at least 4 characters

0 matches for: 'emtricitabine' in the Therapeutic Groups

3 results showing for: 'emtricitabine'

Efavirenz with emtricitabine and tenofovir disoproxil

  • Restricted. Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a maleate) - 1% DV Jun-19 to 2022 (HSS)
    • Brand Mylan
    • Pharmacode2558505
    • Subsidy $106.88
    • Measure / Qty per 30
RS1572 - Nucleoside Reverse Transcriptase Inhibitors
  • Restricted. Cap 200 mg - 1% DV Jul-19 to 2022 (HSS)
    • Brand Emtriva
    • Pharmacode2250063
    • Subsidy $307.20
    • Measure / Qty per 30
RS1572 - Nucleoside Reverse Transcriptase Inhibitors

Emtricitabine with tenofovir disoproxil

  • Restricted. Tab 200 mg with tenofovir disoproxil 245 mg (300.6 mg as a succinate) - 1% DV Jun-19 to 2022 (HSS)
    • Brand Teva
    • Pharmacode2560488
    • Subsidy $61.15
    • Measure / Qty per 30
RS1800 - Emtricitabine with tenofovir disoproxil
  • Rectangle page icon symoblising a PDF. PDF
  • Two duplicate pages icon. Click to copy
  • Restriction. Restriction
  • HSS Hospital Supply Status
  • PSS Principal Supply Status
  • dv DV Limit Gives the maximum volume that can be purchased of other brands
  • B Bolded Pharmacode means that the product is to be delisted soon